January 31, 2023 Comments Off on New patent for Allergan drug DALVANCE Posted in: Patent Added Annual Drug Patent Expirations for DALVANCE Dalvance is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Allergan drug DALVANCE appeared first on DrugP…
January 27, 2023 Comments Off on New patent for Janssen Biotech drug ERLEADA Posted in: Patent Added Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…